Prosecution Insights
Last updated: November 04, 2026

Glycosbio Inc.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Glycosbio Inc. currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are assigned to 2 distinct examiners. The prosecution activity is distributed across distinct art units. These figures indicate that the company's active matters are spread among multiple reviewers and administrative divisions. This distribution provides a variety of examiner perspectives within the Biotechnology & Pharmaceuticals sector.

ARNOLD, ERNST V is the busiest examiner for the company and is responsible for 1 pending office action. This busiest examiner pending count of 1 is less than the total count of pending office actions. Because the workload is split, the company's prosecution success does not depend on a single examiner. Practitioners must manage different examination styles across the distinct examiners and art units. This arrangement requires a strategy that accounts for the specific requirements of each assigned reviewer. The current prosecution profile is characterized by this distribution of matters across the staff.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (50%)
1
Easy (50%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
§112 only1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ARNOLD, ERNST V 1 48.2% +12.7%
O'HERN, BRENT T 1 78.7% +19.3%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18379449 DRUG DELIVERY VIA MONOACYLGLYCEROL AND FREE FATTY ACID-BASED COMPOSITIONS ARNOLD, ERNST V —
18155441 METHOD OF MAKING MONOACYLGLYCERIDE OILS AND FOOD PRODUCTS CONTAINING MONOACYLGLYCERIDE OILS O'HERN, BRENT T —

Top Art Units

Art UnitApps
1626 1
1793 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18379449 DRUG DELIVERY VIA MONOACYLGLYCEROL AND FREE FATTY ACID-BASED COMPOSITIONS ARNOLD, ERNST V 1626 §103 Final Rejection — Pending Oct 12, 2023
18155441 METHOD OF MAKING MONOACYLGLYCERIDE OILS AND FOOD PRODUCTS CONTAINING MONOACYLGLYCERIDE OILS O'HERN, BRENT T 1793 §112 Non-Final OA — Pending Jan 17, 2023

Managing Glycosbio Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Glycosbio Inc. have?

Glycosbio Inc. has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Glycosbio Inc. applications?

Ernst V Arnold has the most, with 1 of Glycosbio Inc.'s pending office actions.

What technology area are Glycosbio Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month